We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NRSN market cap is 21.77M. The company's latest EPS is USD -0.5794 and P/E is -0.69.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.75M | -3.29M | -2.99M | -3.03M | -2.11M |
| Net Income | 784k | -2.95M | -5.4M | -857k | -2.15M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.24M | -2.89M | -5.59M | -13.55M | -13.3M |
| Net Income | -1.22M | -2.83M | -4.04M | -12.34M | -11.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.39M | 3.18M | 1.45M | 1.84M | 984k |
| Total Liabilities | 5.58M | 5.05M | 8.44M | 3.54M | 3.8M |
| Total Equity | -196k | -1.87M | -6.99M | -1.7M | -2.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 955k | 779k | 11.43M | 7.71M | 3.18M |
| Total Liabilities | 37k | 120k | 2.43M | 2.09M | 5.05M |
| Total Equity | 918k | 659k | 9.01M | 5.62M | -1.87M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -8.45M | N/A | -5.75M | N/A |
| Investing | N/A | 3.65M | N/A | 1,000 | N/A |
| Financing | N/A | 3.9M | N/A | 4.32M | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -582k | -695k | -1.54M | -7.59M | -8.45M |
| Investing | -26k | -9k | -17k | -3.54M | 3.65M |
| Financing | 1.42M | 508k | 11.9M | 3.7M | 3.9M |
| Market Cap | 21.77M |
| Price to Earnings Ratio | -0.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.95 |
| Price to Book Ratio | -4.16 |
| Dividend Yield | - |
| Shares Outstanding | 19.47M |
| Average Volume (1 week) | 122.83k |
| Average Volume (1 Month) | 472.1k |
| 52 Week Change | 33.08% |
| 52 Week High | 2.33 |
| 52 Week Low | 0.512 |
| Spread (Intraday) | 0.04 (3.48%) |
| Company Name | NeuroSense Therapeutics Ltd |
| Address |
medinat ha-yehudim street, 85 herzliya, center |
| Website | https://www.neurosense-tx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
